To innovate industries, transform businesses, connect communities, and drive meaningful change, we must think bigger, reach broader, and act bolder. Through knowledge, curiosity, and collaboration, Compugen helps organizations deliver experience by design. This is what it means to be human-centred and technology-enabled. We believe that partner is a verb. With Compugen as your ally from day one, you see and feel the difference. This is where inspiration meets impact. Relentlessly Curious We think differently. We ask questions in an unending pursuit to uncover your why. From the way we engage internally to the bonds we build with our customers and community, this no-stone-unturned passion translates possibility into reality. Collaborative at the Core We are grounded in the potential of technology and the impact of people. Through deep discussion and challenging inquiry, we embrace diverse perspectives and celebrate unique views. With true trust in each other creative ideas flow, goals are achieved, and innovation abounds. Driven to Make a Difference When you have innovation at hand and intention in your heart, one person can drive change. With one word, one device, one connection; change ignites, and all will flourish. Get an Ally in Your Technology Journey. We deliver experience by design; visit compugen.com to start now: #DreamDesignDeliver
Location: Canada, Ontario, Richmond Hill
Employees: 1001-5000
Founded date: 1981
Mentions in press and media 8
| Date | Title | Description |
| 10.02.2026 | Final Results | Final Results Tue, Feb 10, 2026 08:00 CET Report this content 10 February 2026 AstraZeneca results: FY and Q4 2025 Strong commercial performance and excellent pipeline delivery in a continuing catalyst-rich period Revenue and EPS summary FY... |
| 22.11.2024 | Converge Bio: The Future of Drug Discovery Speaks the Language of Life | In the world of pharmaceuticals, time is a luxury few can afford. The process of drug discovery is a labyrinthine journey, often taking a decade or more, with costs spiraling past a billion dollars. Yet, a new player has entered the arena, ... |
| 22.11.2024 | Converge Bio raises $5.5M to expedite drug discovery, development with GenAI | Photo: mediaphotos/Getty Images Converge Bio has raised $5.5 million in seed funding led by TLV Partners. WHAT IT DOES Converge Bio is a generative AI hub for Biotech and Pharma that allows the accelerated discovery and development of drugs... |
| 21.11.2024 | Converge Bio Raises $5.5M to Accelerate Drug Discovery with GenAI | What You Should Know: – Converge Bio, a generative AI platform for accelerated drug discovery and development, today announced it has raised $5.5 million in seed funding, led by TLV Partners. – Converge Bio’s platform uses large language mo... |
| 05.11.2024 | Compugen Strengthens Defence + Security Industry with Strategic Acquisition of SynerSolutions | TORONTO, Nov. 5, 2024 /PRNewswire/ -- Compugen Inc., the nation's largest privately-owned and operated Technology Ally, is proud to announce the acquisition of SynerSolutions Technologies Inc., a leader in cybersecurity services for defence... |
| 04.07.2024 | Bridging Gaps + Building Futures: Compugen Partners with Sun Youth for Inclusive Education | Cutting-edge technology fosters educational equity RICHMOND HILL, ON, July 4, 2024 /PRNewswire/ -- Compugen Inc., the nation's largest privately-owned and operated Technology Ally, is proud to announce a philanthropic contribution to Sun Yo... |
| 01.02.2024 | Compugen Welcomes Kara Rudy as Vice President, Marketing | Richmond Hill, On, (ANTARA/PRNewswire) - Compugen Inc., the nation's largest privately-owned and operated Technology Ally, is pleased to announce MarketDesign Consulting Founder + CMO Kara Rudy has officially joined Compugen Inc. as its new... |
| 19.11.2012 | [Update] Funding Daily: Social butterflies | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today! When in doubt, put a “social” on it. Three out of... |